• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病:即使在考虑冠状动脉疾病的程度和血运重建的益处之后,仍是不稳定型冠状动脉疾病的主要危险因素。

Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.

作者信息

Norhammar Anna, Malmberg Klas, Diderholm Erik, Lagerqvist Bo, Lindahl Bertil, Rydén Lars, Wallentin Lars

机构信息

Department of Cardiology, Karolinska Hospital, Stockholm, Sweden.

出版信息

J Am Coll Cardiol. 2004 Feb 18;43(4):585-91. doi: 10.1016/j.jacc.2003.08.050.

DOI:10.1016/j.jacc.2003.08.050
PMID:14975468
Abstract

OBJECTIVES

This study was designed to study the influence of diabetes on the outcome of unstable coronary artery disease (CAD).

BACKGROUND

Diabetes mellitus is a major contributor to CAD. Despite improvement in the management of patients with unstable coronary syndromes, this condition is still linked to a substantially increased mortality and morbidity among diabetic patients. Recent evidence advocates early revascularization in unstable coronary syndromes. Diabetic patients subjected to coronary interventions under stable conditions have a higher risk for complications and a more dismal prognosis than nondiabetic subjects. Accordingly, it is of considerable interest to obtain further information regarding the best possible management of diabetic patients with unstable CAD.

METHODS

A total of 2158 patients without and 299 with diabetes mellitus were randomized to an early invasive or a noninvasive strategy. The severity of CAD was expressed as the number and extent of vessel involvement.

RESULTS

Three-vessel disease was diagnosed in 42% of diabetic and 31% of nondiabetic patients (p = 0.006). The percentages of patients with ST-depression and troponin-T >0.03 microg/l at admission were comparable among diabetic and nondiabetic patients. Mortality and reinfarction after 12 months were more frequent among diabetic than nondiabetic patients in both treatment groups. Diabetes remained a strong independent predictor for death and myocardial infarction in multivariable analysis. The invasive strategy reduced event rate in nondiabetic patients from 12.0% to 8.9% (odds ratio [OR] = 0.72; confidence interval [CI] 0.54 to 0.95; p = 0.019) and in diabetic patients from 29.9% to 20.6% (OR 0.61; CI 0.36 to 1.04; p = 0.066). In a multivariate analysis including the extent of CAD, diabetes remained a strong independent predictor of the combined end point (relative risk [RR] 2.40; CI 1.47 to 3.91; p = 0.0001) and of mortality (RR 5.43; CI 2.09 to 14.12; p = 0.001).

CONCLUSIONS

An invasive strategy improved outcome for both diabetic and nondiabetic patients with unstable CAD. However, diabetes mellitus remained an independent and important risk factor for death and myocardial infarction in the invasive group. Thus, factors beyond the extent of flow-limiting coronary lesions are of considerable importance for outcome in diabetic subjects with unstable coronary syndromes.

摘要

目的

本研究旨在探讨糖尿病对不稳定型冠状动脉疾病(CAD)预后的影响。

背景

糖尿病是CAD的主要促成因素。尽管不稳定型冠状动脉综合征患者的管理有所改善,但这种情况在糖尿病患者中仍与死亡率和发病率的大幅增加相关。最近的证据支持在不稳定型冠状动脉综合征中尽早进行血运重建。与非糖尿病患者相比,在稳定条件下接受冠状动脉介入治疗的糖尿病患者发生并发症的风险更高,预后更差。因此,获取有关不稳定型CAD糖尿病患者最佳管理的更多信息具有重要意义。

方法

将2158例非糖尿病患者和299例糖尿病患者随机分为早期侵入性策略组或非侵入性策略组。CAD的严重程度用血管受累的数量和范围表示。

结果

42%的糖尿病患者和31%的非糖尿病患者被诊断为三支血管病变(p = 0.006)。糖尿病患者和非糖尿病患者入院时ST段压低和肌钙蛋白-T>0.03μg/l的患者百分比相当。在两个治疗组中,糖尿病患者12个月后的死亡率和再梗死发生率均高于非糖尿病患者。在多变量分析中,糖尿病仍然是死亡和心肌梗死的强有力独立预测因素。侵入性策略使非糖尿病患者的事件发生率从12.0%降至8.9%(优势比[OR]=0.72;置信区间[CI]0.54至0.95;p = 0.019),糖尿病患者从29.9%降至20.6%(OR 0.61;CI 0.36至1.04;p = 0.066)。在包括CAD范围的多变量分析中,糖尿病仍然是联合终点(相对风险[RR]2.40;CI 1.47至3.91;p = 0.0001)和死亡率(RR 5.43;CI 2.09至14.12;p = 0.001)的强有力独立预测因素。

结论

侵入性策略改善了不稳定型CAD糖尿病患者和非糖尿病患者的预后。然而,糖尿病在侵入性治疗组中仍然是死亡和心肌梗死的独立且重要的危险因素。因此,除了限流性冠状动脉病变范围之外的因素对不稳定型冠状动脉综合征糖尿病患者的预后也非常重要。

相似文献

1
Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.糖尿病:即使在考虑冠状动脉疾病的程度和血运重建的益处之后,仍是不稳定型冠状动脉疾病的主要危险因素。
J Am Coll Cardiol. 2004 Feb 18;43(4):585-91. doi: 10.1016/j.jacc.2003.08.050.
2
Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.糖尿病患者与非糖尿病患者的多支冠状动脉血运重建:ARTS-II(动脉血运重建治疗研究 - 第二部分)试验的3年随访
J Am Coll Cardiol. 2008 Dec 9;52(24):1957-67. doi: 10.1016/j.jacc.2008.09.010.
3
Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.糖尿病对非体外循环冠状动脉搭桥手术长期生存的影响。
Ann Thorac Surg. 2008 Oct;86(4):1181-8. doi: 10.1016/j.athoracsur.2008.06.063.
4
Impact of diabetes on outcome following isolated minimally invasive bypass grafting of the left anterior descending artery.糖尿病对单纯微创左前降支搭桥术后结局的影响。
Ann Thorac Surg. 2004 Jul;78(1):129-34. doi: 10.1016/j.athoracsur.2004.03.008.
5
Diabetes does not influence treatment decisions regarding revascularization in patients with stable coronary artery disease.糖尿病不影响稳定型冠状动脉疾病患者血管重建治疗决策。
Diabetes Care. 2006 Sep;29(9):2003-11. doi: 10.2337/dc06-0118.
6
ST depression in ECG at entry indicates severe coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease; the FRISC II ECG substudy. The Fast Revascularisation during InStability in Coronary artery disease.入院时心电图ST段压低提示在不稳定型冠状动脉疾病中存在严重冠状动脉病变以及早期侵入性治疗策略的巨大益处;FRISC II心电图亚组研究。冠状动脉疾病不稳定期快速血运重建研究。
Eur Heart J. 2002 Jan;23(1):41-9. doi: 10.1053/euhj.2001.2694.
7
FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease.用于选择不稳定型冠状动脉疾病早期侵入性治疗策略患者的FRISC评分。
Heart. 2005 Aug;91(8):1047-52. doi: 10.1136/hrt.2003.031369.
8
Prognostic significance of asymptomatic coronary artery disease in patients with diabetes and need for early revascularization therapy.无症状性冠状动脉疾病在糖尿病患者中的预后意义及早期血运重建治疗的必要性。
Diabet Med. 2007 Sep;24(9):1003-11. doi: 10.1111/j.1464-5491.2007.02182.x. Epub 2007 May 17.
9
[Twelve-month outcome of 658 patients with acute coronary syndrome without ST-segment elevation assigned to early invasive strategy].658例非ST段抬高型急性冠脉综合征患者采用早期侵入性策略的12个月结局
Wiad Lek. 2006;59(7-8):497-501.
10
Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.基于证据的药物治疗和血运重建:糖尿病和冠心病患者管理的有力工具:欧洲心脏调查糖尿病与心脏报告
Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):216-23. doi: 10.1097/HJR.0b013e3282f335d0.

引用本文的文献

1
Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary intervention.糖尿病对接受经皮冠状动脉介入治疗的ST段抬高型心肌梗死合并多支冠状动脉疾病患者预后的影响。
Clin Res Cardiol. 2025 Sep 10. doi: 10.1007/s00392-025-02745-x.
2
Short-term outcomes of off-pump vs. on-pump coronary artery bypass grafting in left main coronary artery disease: a systematic review and meta-analysis.非体外循环与体外循环冠状动脉旁路移植术治疗左主干冠状动脉疾病的短期结局:一项系统评价和荟萃分析
Indian J Thorac Cardiovasc Surg. 2025 Jul;41(7):852-862. doi: 10.1007/s12055-025-01907-w. Epub 2025 Mar 6.
3
Drug-coated balloons in percutaneous coronary interventions: existing evidence and emerging hopes.
经皮冠状动脉介入治疗中的药物涂层球囊:现有证据与新希望
Cardiol J. 2025;32(3):308-320. doi: 10.5603/cj.101393. Epub 2025 Apr 14.
4
Impact of Diabetes Mellitus on Coronary Artery Disease Severity: A Comparative Analysis of Diabetic and Non-diabetic Patients.糖尿病对冠状动脉疾病严重程度的影响:糖尿病患者与非糖尿病患者的比较分析。
Cureus. 2025 Jan 12;17(1):e77344. doi: 10.7759/cureus.77344. eCollection 2025 Jan.
5
The Predictive Value of TyG Index and NLR for Risk of CHD and the Severity of Coronary Artery Lesions in Patients with Type 2 Diabetes Mellitus.TyG指数和中性粒细胞与淋巴细胞比值对2型糖尿病患者冠心病风险及冠状动脉病变严重程度的预测价值
J Inflamm Res. 2024 Dec 28;17:11813-11828. doi: 10.2147/JIR.S496419. eCollection 2024.
6
Comprehensive analysis of the association between triglyceride-glucose index and coronary artery disease severity across different glucose metabolism states: a large-scale cross-sectional study from an Asian cohort.不同糖代谢状态下甘油三酯-葡萄糖指数与冠状动脉疾病严重程度的相关性综合分析:来自亚洲队列的大规模横断面研究。
Cardiovasc Diabetol. 2024 Jul 13;23(1):251. doi: 10.1186/s12933-024-02355-3.
7
Association between C-Reactive Protein to Albumin Ratio and Multi-Vessel Coronary Artery Disease in Patients with Stable Coronary Artery Disease.稳定性冠心病患者C反应蛋白与白蛋白比值和多支冠状动脉疾病的关联
J Pers Med. 2024 Mar 31;14(4):378. doi: 10.3390/jpm14040378.
8
Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stents: Patient-Level Pooled Analysis From Two Indian Registries.超薄支柱可生物降解聚合物涂层西罗莫司洗脱冠状动脉支架:来自两个印度注册研究的患者水平汇总分析。
Cureus. 2023 Jul 11;15(7):e41743. doi: 10.7759/cureus.41743. eCollection 2023 Jul.
9
Association between monocyte to high-density lipoprotein cholesterol ratio and multi-vessel coronary artery disease: a cross-sectional study.单核细胞/高密度脂蛋白胆固醇比值与多支冠状动脉疾病的相关性:一项横断面研究。
Lipids Health Dis. 2023 Aug 8;22(1):121. doi: 10.1186/s12944-023-01897-x.
10
Safety and efficacy of perioperative continuous renal replacement therapy for percutaneous coronary intervention in severe acute myocardial infarction patients.围手术期连续性肾脏替代治疗在严重急性心肌梗死患者经皮冠状动脉介入治疗中的安全性和疗效。
J Med Life. 2023 May;16(5):719-724. doi: 10.25122/jml-2022-0270.